D M Ouwens1, M Diamant2, M Fodor3, D D J Habets4, M M A L Pelsers4, M El Hasnaoui4, Z C Dang2,5, C E van den Brom6,2,5, R Vlasblom6,2,5, A Rietdijk6, C Boer5, S L M Coort4, J F C Glatz4, J J F P Luiken4,7. 1. Department of Molecular Cell Biology, Section of Signal Transduction and Ageing, Leiden University Medical Centre, Postzone S1-P, P.O. Box 9600, NL-2300, RC Leiden, The Netherlands. d.m.ouwens@lumc.nl. 2. Department of Endocrinology, Diabetes Centre, VU University Medical Centre, Amsterdam, the Netherlands. 3. Department of Anatomy and Embryology/Central Animal Facility, Leiden University Medical Centre, Leiden, the Netherlands. 4. Department of Molecular Genetics, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, the Netherlands. 5. Laboratory for Physiology, VU University Medical Centre, Amsterdam, the Netherlands. 6. Department of Molecular Cell Biology, Section of Signal Transduction and Ageing, Leiden University Medical Centre, Postzone S1-P, P.O. Box 9600, NL-2300, RC Leiden, The Netherlands. 7. Department of Biochemical Physiology and Institute of Biomembranes, Utrecht University, Utrecht, the Netherlands.
Abstract
AIMS/HYPOTHESIS: Changes in cardiac substrate utilisation leading to altered energy metabolism may underlie the development of diabetic cardiomyopathy. We studied cardiomyocyte substrate uptake and utilisation and the role of the fatty acid translocase CD36 in relation to in vivo cardiac function in rats fed a high-fat diet (HFD). METHODS: Rats were exposed to an HFD or a low-fat diet (LFD). In vivo cardiac function was monitored by echocardiography. Substrate uptake and utilisation were determined in isolated cardiomyocytes. RESULTS: Feeding an HFD for 8 weeks induced left ventricular dilation in the systolic phase and decreased fractional shortening and the ejection fraction. Insulin-stimulated glucose uptake and proline-rich Akt substrate 40 phosphorylation were 41% (p < 0.001) and 45% (p < 0.05) lower, respectively, in cardiomyocytes from rats on the HFD. However, long-chain fatty acid (LCFA) uptake was 1.4-fold increased (p < 0.001) and LCFA esterification into triacylglycerols and phospholipids was increased 1.4- and 1.5-fold, respectively (both p < 0.05), in cardiomyocytes from HFD compared with LFD hearts. In the presence of the CD36 inhibitor sulfo-N-succinimidyloleate, LCFA uptake and esterification were similar in LFD and HFD cardiomyocytes. In HFD hearts CD36 was relocated to the sarcolemma, and basal phosphorylation of a mediator of CD36-trafficking, i.e. protein kinase B (PKB/Akt), was increased. CONCLUSIONS/ INTERPRETATION: Feeding rats an HFD induced cardiac contractile dysfunction, which was accompanied by the relocation of CD36 to the sarcolemma, and elevated basal levels of phosphorylated PKB/Akt. The permanent presence of CD36 at the sarcolemma resulted in enhanced rates of LCFA uptake and myocardial triacylglycerol accumulation, and may contribute to the development of insulin resistance and diabetic cardiomyopathy.
AIMS/HYPOTHESIS: Changes in cardiac substrate utilisation leading to altered energy metabolism may underlie the development of diabetic cardiomyopathy. We studied cardiomyocyte substrate uptake and utilisation and the role of the fatty acid translocase CD36 in relation to in vivo cardiac function in rats fed a high-fat diet (HFD). METHODS:Rats were exposed to an HFD or a low-fat diet (LFD). In vivo cardiac function was monitored by echocardiography. Substrate uptake and utilisation were determined in isolated cardiomyocytes. RESULTS: Feeding an HFD for 8 weeks induced left ventricular dilation in the systolic phase and decreased fractional shortening and the ejection fraction. Insulin-stimulated glucose uptake and proline-rich Akt substrate 40 phosphorylation were 41% (p < 0.001) and 45% (p < 0.05) lower, respectively, in cardiomyocytes from rats on the HFD. However, long-chain fatty acid (LCFA) uptake was 1.4-fold increased (p < 0.001) and LCFA esterification into triacylglycerols and phospholipids was increased 1.4- and 1.5-fold, respectively (both p < 0.05), in cardiomyocytes from HFD compared with LFD hearts. In the presence of the CD36 inhibitor sulfo-N-succinimidyloleate, LCFA uptake and esterification were similar in LFD and HFD cardiomyocytes. In HFD hearts CD36 was relocated to the sarcolemma, and basal phosphorylation of a mediator of CD36-trafficking, i.e. protein kinase B (PKB/Akt), was increased. CONCLUSIONS/ INTERPRETATION: Feeding rats an HFD induced cardiac contractile dysfunction, which was accompanied by the relocation of CD36 to the sarcolemma, and elevated basal levels of phosphorylated PKB/Akt. The permanent presence of CD36 at the sarcolemma resulted in enhanced rates of LCFA uptake and myocardial triacylglycerol accumulation, and may contribute to the development of insulin resistance and diabetic cardiomyopathy.
Authors: Heinrich Taegtmeyer; Leonard Golfman; Saumya Sharma; Peter Razeghi; Melissa van Arsdall Journal: Ann N Y Acad Sci Date: 2004-05 Impact factor: 5.691
Authors: Emmani B M Nascimento; Mariann Fodor; Gerard C M van der Zon; Ingrid M Jazet; A Edo Meinders; Peter J Voshol; Ronald Vlasblom; Bart Baan; Jürgen Eckel; J Antonie Maassen; Michaela Diamant; D Margriet Ouwens Journal: Diabetes Date: 2006-12 Impact factor: 9.461
Authors: Daphna D J Habets; Will A Coumans; Peter J Voshol; Marion A M den Boer; Maria Febbraio; Arend Bonen; Jan F C Glatz; Joost J F P Luiken Journal: Biochem Biophys Res Commun Date: 2007-02-02 Impact factor: 3.575
Authors: Pradip K Mazumder; Brian T O'Neill; Matthew W Roberts; Jonathan Buchanan; Ui Jeong Yun; Robert C Cooksey; Sihem Boudina; E Dale Abel Journal: Diabetes Date: 2004-09 Impact factor: 9.461
Authors: Susan L M Coort; Danny M Hasselbaink; Debby P Y Koonen; Jodil Willems; Will A Coumans; Adrian Chabowski; Ger J van der Vusse; Arend Bonen; Jan F C Glatz; Joost J F P Luiken Journal: Diabetes Date: 2004-07 Impact factor: 9.461
Authors: John Yang; Nandakumar Sambandam; Xianlin Han; Richard W Gross; Michael Courtois; Attila Kovacs; Maria Febbraio; Brian N Finck; Daniel P Kelly Journal: Circ Res Date: 2007-03-15 Impact factor: 17.367
Authors: Annayya R Aroor; James R Sowers; Shawn B Bender; Ravi Nistala; Mona Garro; Irina Mugerfeld; Melvin R Hayden; Megan S Johnson; Muhammad Salam; Adam Whaley-Connell; Vincent G Demarco Journal: Endocrinology Date: 2013-05-07 Impact factor: 4.736
Authors: Sihem Boudina; Heiko Bugger; Sandra Sena; Brian T O'Neill; Vlad G Zaha; Olesya Ilkun; Jordan J Wright; Pradip K Mazumder; Eric Palfreyman; Timothy J Tidwell; Heather Theobald; Oleh Khalimonchuk; Benjamin Wayment; Xiaoming Sheng; Kenneth J Rodnick; Ryan Centini; Dong Chen; Sheldon E Litwin; Bart E Weimer; E Dale Abel Journal: Circulation Date: 2009-02-23 Impact factor: 29.690
Authors: Andrew N Carley; Jian Bi; Xuerong Wang; Natasha H Banke; Jason R B Dyck; J Michael O'Donnell; E Douglas Lewandowski Journal: J Lipid Res Date: 2012-10-25 Impact factor: 5.922
Authors: Jordan J Wright; Jaetaek Kim; Jonathan Buchanan; Sihem Boudina; Sandra Sena; Kyriaki Bakirtzi; Olesya Ilkun; Heather A Theobald; Robert C Cooksey; Kostantin V Kandror; E Dale Abel Journal: Cardiovasc Res Date: 2009-01-15 Impact factor: 10.787